A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4044 participants.

Also called NCT06694727

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 4,044 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06694727
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06694727. Randomized; quadruple masking; primary purpose treatment. Start 2025-09-30 (actual); primary completion 2028-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure
Acronym
DANUTRIO-HF
Condition
Heart Failure
Intervention (Dietary supplement)
Coenzyme Q10 100 Milligrams Oral Capsule
Intervention (Dietary supplement)
Selenium 100 Micrograms Oral Tablets
Lead sponsor
Tor Biering-Sørensen (class: other)
Collaborator
Pharma Nord (class: industry)

Record details

Record id
cardio:ct-nct06694727
Content hash
31d1a9eacd832376c7ecf5c06f726e75dd62edac029b7ffef8cab14082ab2e3e